| |
Group A(n=32) |
Group B (n=41) |
p-value |
| Increases in Scr (x) |
1.39±0.61 |
1.19±0.34 |
0.107 |
| Urine volume(mL/day) |
2304±1372 |
1608±1061 |
0.016 |
| Fluid therapy(mL/day) |
2457±667 |
1938±472 |
<.001 |
| Changes in body weight (%) |
5.12±6.82 |
2.94±6.65 |
0.032 |
| CVP(mmHg) |
6.6±3.4 |
4.2±3.1 |
0.003 |
| SOFA score |
10.7±2.2 |
7.6±2.7 |
<.001 |
| Cardiovascular |
2.3±0.7 |
1.5±0.8 |
<.001 |
| Respiratory |
1.5±0.7 |
1.1±0.8 |
0.043 |
| coagulation |
1.6±0.8 |
1.3±1.0 |
0.264 |
| Liver |
1.9±1.3 |
1.2±1.1 |
0.005 |
| Renal |
1.1±1.1 |
1.7±1.2 |
0.046 |
| Organ damage |
8.5±2.1 |
6.7±2.5 |
0.001 |
| Dose of dialysis(ml/hr/kg) |
9.6±4.3 |
9.1±2.4 |
0.549 |
| Duration of CRRT(day) |
7.0±6.6 |
7.0±3.8 |
0.148 |
|
| Values are expressed as mean + standard deviation. Scr, serum creatinine; CVP, central venous pressure; SOFA, sequential organ failure assessment; CRRT, continuous renal replacement therapy. |
| Table 2: Characteristics of patients with (group A) or without (group B) support of mechanical ventilation at the timing of cessation of continuous renal replacement therapy. |
